KOBAYASHI PHARMACEUTICAL CO.,LTD.JP:4967Balance sheet

Market cap
¥428.3B
P/E ratio
38.9x
2014/032015/032016/032016/122017/122018/122019/122020/122021/122022/122023/122024/12
Cash and cash equivalents -58,44961,42858,17364,99074,45675,58078,25395,02496,23371,53650,873
Marketable securities, current -4,5004,5005,5008,3008,30014,97716,08514,0228,3008,30014,872
Accounts receivable, net-35,96936,08847,04550,03253,38654,81852,85055,16947,88153,02849,442
Inventories-8,99610,3789,2229,7899,43010,2038,9608,8539,98513,30815,143
Total current assets-115,990120,347128,646142,346155,058162,712164,225181,889172,892158,331144,468
Property, plant and equipment, net-16,02317,18717,83318,24719,02421,18020,82122,52434,77847,66567,448
Marketable securities, non-current -41,58039,65640,28146,79745,91639,53334,47429,46628,50932,12424,617
Total non-current assets-70,34068,65072,58776,48475,93070,68574,14170,66482,934109,142120,900
Total assets -186,331188,997201,234218,831230,989233,398238,366252,554255,827267,473265,368
Accounts payable-10,2397,1418,1698,2798,7068,2767,5589,2939,0518,7458,264
Short-term debt-4018119219450619131---
Total current liabilities-35,89036,48146,97554,27455,21553,43350,10750,70351,80956,11146,423
Total non-current liabilities-10,82910,49210,93810,7449,5247,3075,6756,2506,1186,5455,473
Total liabilities -46,72046,97457,91465,01964,74060,74055,78356,95457,92762,65651,896
Common stock and paid-in capital -7,6698,4038,4087,6337,6337,6337,6337,6333,9723,9723,972
Retained earnings-127,858137,486147,901146,758159,857173,650187,071200,534194,285205,681208,240
Stockholders' equity126,953139,611142,023143,320153,811166,249172,657182,583195,600197,900204,816213,471